| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 547 | 2021 |
| Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry G Boriani, C Laroche, I Diemberger, E Fantecchi, MI Popescu, ... The American journal of medicine 128 (5), 509-518. e2, 2015 | 375 | 2015 |
| Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot … GYH Lip, C Laroche, G Boriani, P Cimaglia, GA Dan, M Santini, Z Kalarus, ... Ep Europace 17 (1), 24-31, 2015 | 221 | 2015 |
| Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF … GYH Lip, C Laroche, MI Popescu, LH Rasmussen, L Vitali-Serdoz, ... EP Europace 17 (12), 1777-1786, 2015 | 173 | 2015 |
| 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 155 | 2016 |
| Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ... Journal of the American Heart Association 5 (3), e002197, 2016 | 154 | 2016 |
| Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation GYH Lip, C Laroche, MI Popescu, LH Rasmussen, L Vitali‐Serdoz, ... European journal of heart failure 17 (6), 570-582, 2015 | 110 | 2015 |
| ‘Real-world’management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme–Atrial Fibrillation … G Boriani, C Laroche, I Diemberger, E Fantecchi, MI Popescu, ... EP Europace 18 (5), 648-657, 2016 | 80 | 2016 |
| Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial … M Proietti, G Boriani, C Laroche, I Diemberger, MI Popescu, ... Europace 19 (4), 535-543, 2017 | 75 | 2017 |
| Stroke prevention in atrial fibrillation and ‘real world’adherence to guidelines in the Balkan Region: The BALKAN-AF Survey TS Potpara, GA Dan, E Trendafilova, A Goda, Z Kusljugic, S Manola, ... Scientific reports 6 (1), 20432, 2016 | 66 | 2016 |
| Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes G Boriani, C Laroche, I Diemberger, MI Popescu, LH Rasmussen, ... Scientific reports 6 (1), 30271, 2016 | 63 | 2016 |
| Age-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: the EORP-AF General Pilot Registry (EURObservational Research … S Fumagalli, SAM Said, C Laroche, D Gabbai, N Marchionni, G Boriani, ... JACC: Clinical Electrophysiology 1 (4), 326-334, 2015 | 63 | 2015 |
| Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 21 (7), 1013-1022, 2019 | 61 | 2019 |
| Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... European journal of heart failure 22 (11), 2160-2171, 2020 | 55 | 2020 |
| Optimizing stroke and bleeding risk assessment in patients with atrial fibrillation: a balance of evidence, practicality and precision M Proietti, N Mujovic, TS Potpara Thrombosis and haemostasis 118 (12), 2014-2017, 2018 | 47 | 2018 |
| Acute coronary syndromes in chronic kidney disease: Clinical and therapeutic characteristics MI Moisi, M Rus, S Bungau, DC Zaha, D Uivarosan, O Fratila, DM Tit, ... Medicina 56 (3), 118, 2020 | 44 | 2020 |
| No-reflow after PPCI—A predictor of short-term outcomes in STEMI patients LR Pantea-Roșan, VA Pantea, S Bungau, DM Tit, T Behl, CM Vesa, ... Journal of Clinical Medicine 9 (9), 2956, 2020 | 39 | 2020 |
| Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the … G Boriani, M Proietti, C Laroche, I Diemberger, MI Popescu, S Riahi, ... International Journal of Cardiology 271, 68-74, 2018 | 39 | 2018 |
| Modern oral anticoagulant treatment in patients with atrial fibrillation and heart failure: Insights from the clinical practice OA Tica, O Tica, L Antal, A Hatos, MI Popescu, A Pantea Stoian, OG Bratu, ... Farmacia 66 (6), 972-976, 2018 | 36 | 2018 |
| The Alberta Stroke Program Early CT score (ASPECTS): A predictor of mortality in acute ischemic stroke NO Pop, DM Tit, CC Diaconu, MA Munteanu, EE Babes, M Stoicescu, ... Experimental and therapeutic medicine 22 (6), 1-8, 2021 | 26 | 2021 |
